25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ABSCF (AB Science S.A) Stock Analysis
Buy, Hold or Sell?

Let's analyze AB Science S.A together

I guess you are interested in AB Science S.A. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – AB Science S.A’s Financial Insights
  • 📈 Technical Analysis (TA) – AB Science S.A’s Price Targets

I'm going to help you getting a better view of AB Science S.A. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about AB Science S.A

I send you an email if I find something interesting about AB Science S.A.

1. Quick Overview

1.1. Quick analysis of AB Science S.A (30 sec.)










1.2. What can you expect buying and holding a share of AB Science S.A? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.36
Expected worth in 1 year
$0.64
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
$1.00
Return On Investment
63.4%

For what price can you sell your share?

Current Price per Share
$1.57
Expected price per share
$1.57 - $1.57
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of AB Science S.A (5 min.)




Live pricePrice per Share (EOD)
$1.57
Intrinsic Value Per Share
$-3.27 - $-0.86
Total Value Per Share
$-3.62 - $-1.21

2.2. Growth of AB Science S.A (5 min.)




Is AB Science S.A growing?

Current yearPrevious yearGrowGrow %
How rich?-$23m-$39m$16m69.8%

How much money is AB Science S.A making?

Current yearPrevious yearGrowGrow %
Making money-$13.1m-$14.9m$1.7m13.6%
Net Profit Margin-1,235.6%-1,421.2%--

How much money comes from the company's main activities?

2.3. Financial Health of AB Science S.A (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of AB Science S.A?

Welcome investor! AB Science S.A's management wants to use your money to grow the business. In return you get a share of AB Science S.A.

First you should know what it really means to hold a share of AB Science S.A. And how you can make/lose money.

Speculation

The Price per Share of AB Science S.A is $1.57. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of AB Science S.A.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in AB Science S.A, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.36. Based on the TTM, the Book Value Change Per Share is $0.25 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.21 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of AB Science S.A.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.20-13.0%-0.20-13.0%-0.23-14.7%-0.26-16.6%-0.34-21.7%
Usd Book Value Change Per Share0.2515.8%0.2515.8%-0.21-13.5%-0.02-1.3%-0.04-2.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.2515.8%0.2515.8%-0.21-13.5%-0.02-1.3%-0.04-2.3%
Usd Price Per Share3.84-3.84-9.00-11.12-7.90-
Price to Earnings Ratio-18.88--18.88--38.96--44.06--27.05-
Price-to-Total Gains Ratio15.44-15.44--42.53--16.43-2.78-
Price to Book Ratio-10.77--10.77--14.87--28.68--27.05-
Price-to-Total Gains Ratio15.44-15.44--42.53--16.43-2.78-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.57
Number of shares636
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.25-0.02
Usd Total Gains Per Share0.25-0.02
Gains per Quarter (636 shares)158.21-13.05
Gains per Year (636 shares)632.85-52.22
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
106336230-52-62
20126612560-104-114
30189918890-157-166
40253125220-209-218
50316431550-261-270
60379737880-313-322
70443044210-366-374
80506350540-418-426
90569656870-470-478
100632863200-522-530

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.015.00.00.0%
Book Value Change Per Share1.00.00.0100.0%1.02.00.033.3%2.03.00.040.0%4.06.00.040.0%6.09.00.040.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%2.00.013.013.3%
Total Gains per Share1.00.00.0100.0%1.02.00.033.3%2.03.00.040.0%4.06.00.040.0%6.09.00.040.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of AB Science S.A compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.2490.2490%-0.212+185%-0.021+108%-0.036+115%
Book Value Per Share---0.357-0.3570%-0.605+70%-0.428+20%-0.285-20%
Current Ratio--1.0381.0380%0.904+15%0.974+7%1.417-27%
Debt To Asset Ratio--1.8241.8240%2.496-27%2.116-14%1.719+6%
Debt To Equity Ratio----0%-0%-0%0.371-100%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--203697768.000203697768.0000%524047368.000-61%675296355.200-70%694231428.286-71%
Eps---0.203-0.2030%-0.231+14%-0.261+28%-0.340+67%
Ev To Ebitda Ratio---14.523-14.5230%-41.237+184%-47.013+224%-40.887+182%
Ev To Sales Ratio--191.604191.6040%499.108-62%442.357-57%437.363-56%
Free Cash Flow Per Share---0.292-0.2920%-0.307+5%-0.280-4%-0.349+20%
Free Cash Flow To Equity Per Share---0.016-0.0160%-0.029+83%-0.019+17%-0.044+174%
Gross Profit Margin--1.0441.0440%1.021+2%1.040+0%1.0480%
Intrinsic Value_10Y_max---0.857--------
Intrinsic Value_10Y_min---3.268--------
Intrinsic Value_1Y_max---0.239--------
Intrinsic Value_1Y_min---0.347--------
Intrinsic Value_3Y_max---0.601--------
Intrinsic Value_3Y_min---1.032--------
Intrinsic Value_5Y_max---0.822--------
Intrinsic Value_5Y_min---1.700--------
Market Cap101405358.000-145%248023296.000248023296.0000%581304600.000-57%718234128.000-65%510062491.800-51%
Net Profit Margin---12.356-12.3560%-14.212+15%-11.749-5%-12.740+3%
Operating Margin---13.844-13.8440%-12.944-7%-11.532-17%-12.485-10%
Operating Ratio--14.84414.8440%17.637-16%12.903+15%14.150+5%
Pb Ratio-4.404+59%-10.771-10.7710%-14.869+38%-28.675+166%-27.054+151%
Pe Ratio-7.720+59%-18.882-18.8820%-38.956+106%-44.063+133%-27.046+43%
Price Per Share1.570-145%3.8403.8400%9.000-57%11.120-65%7.897-51%
Price To Free Cash Flow Ratio-5.374+59%-13.145-13.1450%-29.279+123%-41.785+218%-25.662+95%
Price To Total Gains Ratio6.311-145%15.43615.4360%-42.526+375%-16.433+206%2.782+455%
Quick Ratio--0.3370.3370%0.322+5%0.563-40%1.167-71%
Return On Assets---0.470-0.4700%-0.571+22%-0.688+46%-0.720+53%
Return On Equity----0%-0%-0%-0.2530%
Total Gains Per Share--0.2490.2490%-0.212+185%-0.021+108%-0.036+115%
Usd Book Value---23026960.000-23026960.0000%-39094320.000+70%-27675315.200+20%-18426828.800-20%
Usd Book Value Change Per Share--0.2490.2490%-0.212+185%-0.021+108%-0.036+115%
Usd Book Value Per Share---0.357-0.3570%-0.605+70%-0.428+20%-0.285-20%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--203697768.000203697768.0000%524047368.000-61%675296355.200-70%694231428.286-71%
Usd Eps---0.203-0.2030%-0.231+14%-0.261+28%-0.340+67%
Usd Free Cash Flow---18868736.000-18868736.0000%-19854040.000+5%-18084000.000-4%-22557104.800+20%
Usd Free Cash Flow Per Share---0.292-0.2920%-0.307+5%-0.280-4%-0.349+20%
Usd Free Cash Flow To Equity Per Share---0.016-0.0160%-0.029+83%-0.019+17%-0.044+174%
Usd Market Cap101405358.000-145%248023296.000248023296.0000%581304600.000-57%718234128.000-65%510062491.800-51%
Usd Price Per Share1.570-145%3.8403.8400%9.000-57%11.120-65%7.897-51%
Usd Profit---13135560.000-13135560.0000%-14922040.000+14%-16786555.200+28%-21951564.800+67%
Usd Revenue--1063120.0001063120.0000%1049968.000+1%1466228.800-27%1755792.000-39%
Usd Total Gains Per Share--0.2490.2490%-0.212+185%-0.021+108%-0.036+115%
 EOD+1 -7MRQTTM+0 -0YOY+26 -105Y+19 -1710Y+18 -19

3.3 Fundamental Score

Let's check the fundamental score of AB Science S.A based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-7.720
Price to Book Ratio (EOD)Between0-1-4.404
Net Profit Margin (MRQ)Greater than0-12.356
Operating Margin (MRQ)Greater than0-13.844
Quick Ratio (MRQ)Greater than10.337
Current Ratio (MRQ)Greater than11.038
Debt to Asset Ratio (MRQ)Less than11.824
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.470
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of AB Science S.A based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.570
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About AB Science S.A

AB Science S.A., a clinical-stage company, designs and develops novel drugs to various diseases with high unmet medical needs for inflammatory diseases, pathologies affecting peripheral and central nervous system, and cancers in France. The company's lead compound is the masitinib, a tyrosine kinase inhibitor which is in Phase III clinical trials for the treatment of amyotrophic lateral sclerosis, indolent systemic mastocytosis, severe asthma, progressive forms of multiple sclerosis, first line pancreatic cancer with pain, alzheimer's disease, and metastatic castrate-resistant prostate cancer, as well as in Phase II clinical trial to treat Covid-19. It also developing AB8939, a microtubule destabiliser for acute myeloid leukemia. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.

Fundamental data was last updated by Penke on 2025-04-04 00:32:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit AB Science S.A earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare AB Science S.A to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -1,235.6% means that $-12.36 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of AB Science S.A:

  • The MRQ is -1,235.6%. The company is making a huge loss. -2
  • The TTM is -1,235.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,235.6%TTM-1,235.6%0.0%
TTM-1,235.6%YOY-1,421.2%+185.6%
TTM-1,235.6%5Y-1,174.9%-60.7%
5Y-1,174.9%10Y-1,274.0%+99.1%
4.3.1.2. Return on Assets

Shows how efficient AB Science S.A is using its assets to generate profit.

  • Above 5% is considered healthy but always compare AB Science S.A to the Drug Manufacturers - Specialty & Generic industry mean.
  • -47.0% Return on Assets means that AB Science S.A generated $-0.47 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of AB Science S.A:

  • The MRQ is -47.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -47.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-47.0%TTM-47.0%0.0%
TTM-47.0%YOY-57.1%+10.1%
TTM-47.0%5Y-68.8%+21.8%
5Y-68.8%10Y-72.0%+3.2%
4.3.1.3. Return on Equity

Shows how efficient AB Science S.A is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare AB Science S.A to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.0% Return on Equity means AB Science S.A generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of AB Science S.A:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-25.3%+25.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of AB Science S.A.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient AB Science S.A is operating .

  • Measures how much profit AB Science S.A makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare AB Science S.A to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -1,384.4% means the company generated $-13.84  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of AB Science S.A:

  • The MRQ is -1,384.4%. The company is operating very inefficient. -2
  • The TTM is -1,384.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1,384.4%TTM-1,384.4%0.0%
TTM-1,384.4%YOY-1,294.4%-90.1%
TTM-1,384.4%5Y-1,153.2%-231.3%
5Y-1,153.2%10Y-1,248.5%+95.3%
4.3.2.2. Operating Ratio

Measures how efficient AB Science S.A is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 14.84 means that the operating costs are $14.84 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of AB Science S.A:

  • The MRQ is 14.844. The company is inefficient in keeping operating costs low. -1
  • The TTM is 14.844. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ14.844TTM14.8440.000
TTM14.844YOY17.637-2.792
TTM14.8445Y12.903+1.942
5Y12.90310Y14.150-1.248
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of AB Science S.A.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if AB Science S.A is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.04 means the company has $1.04 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of AB Science S.A:

  • The MRQ is 1.038. The company is just able to pay all its short-term debts.
  • The TTM is 1.038. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.038TTM1.0380.000
TTM1.038YOY0.904+0.133
TTM1.0385Y0.974+0.064
5Y0.97410Y1.417-0.443
4.4.3.2. Quick Ratio

Measures if AB Science S.A is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare AB Science S.A to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.34 means the company can pay off $0.34 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of AB Science S.A:

  • The MRQ is 0.337. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.337. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.337TTM0.3370.000
TTM0.337YOY0.322+0.015
TTM0.3375Y0.563-0.226
5Y0.56310Y1.167-0.604
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of AB Science S.A.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of AB Science S.A assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare AB Science S.A to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 1.82 means that AB Science S.A assets are financed with 182.4% credit (debt) and the remaining percentage (100% - 182.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of AB Science S.A:

  • The MRQ is 1.824. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.824. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.824TTM1.8240.000
TTM1.824YOY2.496-0.672
TTM1.8245Y2.116-0.292
5Y2.11610Y1.719+0.397
4.5.4.2. Debt to Equity Ratio

Measures if AB Science S.A is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare AB Science S.A to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of AB Science S.A:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y0.371-0.371
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings AB Science S.A generates.

  • Above 15 is considered overpriced but always compare AB Science S.A to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -18.88 means the investor is paying $-18.88 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of AB Science S.A:

  • The EOD is -7.720. Based on the earnings, the company is expensive. -2
  • The MRQ is -18.882. Based on the earnings, the company is expensive. -2
  • The TTM is -18.882. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.720MRQ-18.882+11.162
MRQ-18.882TTM-18.8820.000
TTM-18.882YOY-38.956+20.074
TTM-18.8825Y-44.063+25.181
5Y-44.06310Y-27.046-17.018
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of AB Science S.A:

  • The EOD is -5.374. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -13.145. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -13.145. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.374MRQ-13.145+7.770
MRQ-13.145TTM-13.1450.000
TTM-13.145YOY-29.279+16.134
TTM-13.1455Y-41.785+28.641
5Y-41.78510Y-25.662-16.123
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of AB Science S.A is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of -10.77 means the investor is paying $-10.77 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of AB Science S.A:

  • The EOD is -4.404. Based on the equity, the company is expensive. -2
  • The MRQ is -10.771. Based on the equity, the company is expensive. -2
  • The TTM is -10.771. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.404MRQ-10.771+6.367
MRQ-10.771TTM-10.7710.000
TTM-10.771YOY-14.869+4.098
TTM-10.7715Y-28.675+17.904
5Y-28.67510Y-27.054-1.622
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Income Tax Expense  4493139-354-2,128-2,124



6.2. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets25,499
Total Liabilities46,509
Total Stockholder Equity-21,010
 As reported
Total Liabilities 46,509
Total Stockholder Equity+ -21,010
Total Assets = 25,499

Assets

Total Assets25,499
Total Current Assets19,390
Long-term Assets6,109
Total Current Assets
Cash And Cash Equivalents 6,066
Net Receivables 236
Inventory 336
Other Current Assets 12,752
Total Current Assets  (as reported)19,390
Total Current Assets  (calculated)19,390
+/-0
Long-term Assets
Property Plant Equipment 785
Intangible Assets 1,403
Long-term Assets Other 3,921
Long-term Assets  (as reported)6,109
Long-term Assets  (calculated)6,109
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities18,683
Long-term Liabilities27,826
Total Stockholder Equity-21,010
Total Current Liabilities
Short-term Debt 2,113
Short Long Term Debt 1,901
Accounts payable 11,075
Other Current Liabilities 4,931
Total Current Liabilities  (as reported)18,683
Total Current Liabilities  (calculated)20,020
+/- 1,337
Long-term Liabilities
Long term Debt 16,606
Capital Lease Obligations 594
Long-term Liabilities Other 9,933
Long-term Liabilities  (as reported)27,826
Long-term Liabilities  (calculated)27,133
+/- 693
Total Stockholder Equity
Common Stock511
Accumulated Other Comprehensive Income -287,450
Other Stockholders Equity 265,929
Total Stockholder Equity (as reported)-21,010
Total Stockholder Equity (calculated)-21,010
+/-0
Other
Capital Stock511
Cash and Short Term Investments 6,066
Common Stock Shares Outstanding 49,665
Current Deferred Revenue5
Liabilities and Stockholders Equity 25,499
Net Debt 13,035
Net Invested Capital -2,503
Net Working Capital 707
Property Plant and Equipment Gross 1,584
Short Long Term Debt Total 19,101



6.3. Balance Sheets Structured

Currency in EUR. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-31
> Total Assets 
14,086
29,398
29,462
29,982
43,633
31,276
32,578
38,010
50,600
22,491
17,740
29,688
21,271
23,841
25,499
25,49923,84121,27129,68817,74022,49150,60038,01032,57831,27643,63329,98229,46229,39814,086
   > Total Current Assets 
13,129
28,205
28,024
27,962
41,573
29,544
30,604
36,118
48,642
20,712
14,085
26,325
18,187
20,872
19,390
19,39020,87218,18726,32514,08520,71248,64236,11830,60429,54441,57327,96228,02428,20513,129
       Cash And Cash Equivalents 
1,785
2,679
11,808
11,746
26,941
13,197
15,696
19,780
38,789
11,560
5,695
20,660
8,721
7,269
6,066
6,0667,2698,72120,6605,69511,56038,78919,78015,69613,19726,94111,74611,8082,6791,785
       Short-term Investments 
3,506
17,203
8,558
11,706
4,504
5,960
6,007
0
0
0
0
0
0
0
0
000000006,0075,9604,50411,7068,55817,2033,506
       Net Receivables 
107
107
136
149
9,780
9,771
8,598
428
2,981
9,000
8,158
355
310
161
236
2361613103558,1589,0002,9814288,5989,7719,780149136107107
       Inventory 
985
832
621
523
349
618
304
134
159
153
230
79
141
456
336
33645614179230153159134304618349523621832985
       Other Current Assets 
6,746
7,384
6,901
3,838
-1
-2
-1
15,776
6,713
-1
2
5,231
9,015
12,986
12,752
12,75212,9869,0155,2312-16,71315,776-1-2-13,8386,9017,3846,746
   > Long-term Assets 
957
1,193
1,438
2,020
2,060
1,732
1,974
1,892
1,957
1,779
3,656
3,363
3,084
2,968
6,109
6,1092,9683,0843,3633,6561,7791,9571,8921,9741,7322,0602,0201,4381,193957
       Property Plant Equipment 
151
156
151
105
187
237
237
211
168
152
2,171
1,823
1,590
1,265
785
7851,2651,5901,8232,171152168211237237187105151156151
       Long Term Investments 
0
0
0
0
0
27
43
48
47
54
0
0
0
0
0
00000544748432700000
       Intangible Assets 
785
1,009
0
1,266
1,290
1,464
1,691
1,630
1,739
1,572
1,417
1,471
1,423
1,626
1,403
1,4031,6261,4231,4711,4171,5721,7391,6301,6911,4641,2901,26601,009785
       Other Assets 
0
0
0
0
0
0
0
0
1
54
-1
67
67
1
0
016767-154100000000
> Total Liabilities 
13,045
14,615
21,731
25,083
43,292
46,957
49,837
42,715
39,865
37,453
44,569
49,237
44,469
59,511
46,509
46,50959,51144,46949,23744,56937,45339,86542,71549,83746,95743,29225,08321,73114,61513,045
   > Total Current Liabilities 
7,965
7,869
9,359
9,710
12,574
13,995
17,612
20,340
18,713
19,200
19,527
22,587
17,482
23,079
18,683
18,68323,07917,48222,58719,52719,20018,71320,34017,61213,99512,5749,7109,3597,8697,965
       Short-term Debt 
0
0
0
316
667
666
229
0
0
6
339
4,728
629
4,695
2,113
2,1134,6956294,728339600229666667316000
       Short Long Term Debt 
0
0
0
0
0
673
236
8
5
11
7
4,370
250
4,303
1,901
1,9014,3032504,3707115823667300000
       Accounts payable 
5,485
4,655
5,233
5,786
8,455
10,192
13,829
16,629
15,483
15,036
15,003
13,286
6,267
7,362
11,075
11,0757,3626,26713,28615,00315,03615,48316,62913,82910,1928,4555,7865,2334,6555,485
       Other Current Liabilities 
2,480
3,214
4,126
3,608
3,452
3,137
3,554
3,711
3,230
3,427
3,441
3,395
8,546
10,486
4,931
4,93110,4868,5463,3953,4413,4273,2303,7113,5543,1373,4523,6084,1263,2142,480
   > Long-term Liabilities 
5,080
6,746
12,372
15,373
30,718
32,962
32,225
22,375
21,152
18,253
25,042
26,650
26,987
36,432
27,826
27,82636,43226,98726,65025,04218,25321,15222,37532,22532,96230,71815,37312,3726,7465,080
       Other Liabilities 
0
0
0
0
0
10,372
10,327
10,017
10,102
10,049
11,014
11,477
12,543
0
0
0012,54311,47711,01410,04910,10210,01710,32710,37200000
> Total Stockholder Equity
1,041
14,783
7,731
4,899
341
-15,681
-17,259
-4,705
10,735
-14,962
-26,829
-19,549
-23,198
-35,670
-21,010
-21,010-35,670-23,198-19,549-26,829-14,96210,735-4,705-17,259-15,6813414,8997,73114,7831,041
   Common Stock
286
311
316
323
329
329
350
386
410
411
435
459
469
469
511
511469469459435411410386350329329323316311286
   Retained Earnings Total Equity000000000000000
   Accumulated Other Comprehensive Income -287,450-270,066-257,591-244,684-230,1550000000000
   Capital Surplus 000000000000000
   Treasury Stock000000000000000
   Other Stockholders Equity 
755
14,472
7,415
4,576
12
-16,010
-17,609
-5,091
10,325
-15,373
202,891
224,676
233,924
233,927
265,929
265,929233,927233,924224,676202,891-15,37310,325-5,091-17,609-16,010124,5767,41514,472755



6.4. Balance Sheets

Currency in EUR. All numbers in thousands.




6.5. Cash Flows

Currency in EUR. All numbers in thousands.




6.6. Income Statements

Currency in EUR. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in EUR. All numbers in thousands.

Gross Profit (+$)
totalRevenue970
Cost of Revenue-383
Gross Profit587587
 
Operating Income (+$)
Gross Profit587
Operating Expense-14,016
Operating Income-13,429-13,429
 
Operating Expense (+$)
Research Development13,927
Selling General Administrative3,017
Selling And Marketing Expenses522
Operating Expense14,01617,466
 
Net Interest Income (+$)
Interest Income2,654
Interest Expense-3,960
Other Finance Cost-4,043
Net Interest Income2,737
 
Pretax Income (+$)
Operating Income-13,429
Net Interest Income2,737
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-11,985-14,873
EBIT - interestExpense = -17,389
-13,923
-8,025
Interest Expense3,960
Earnings Before Interest and Taxes (EBIT)-13,429-8,025
Earnings Before Interest and Taxes (EBITDA)-12,797
 
After tax Income (+$)
Income Before Tax-11,985
Tax Provision-0
Net Income From Continuing Ops-10,047-11,985
Net Income-11,985
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses14,399
Total Other Income/Expenses Net1,444-2,737
 

Technical Analysis of AB Science S.A
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of AB Science S.A. The general trend of AB Science S.A is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine AB Science S.A's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. AB Science S.A Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of AB Science S.A.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 1.57 < 1.57 < 1.57.

The bearish price targets are: 1.57 > 1.57 > 1.57.

Know someone who trades $ABSCF? Share this with them.👇

AB Science S.A Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of AB Science S.A. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

AB Science S.A Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of AB Science S.A.

AB Science S.A Daily Moving Average Convergence/Divergence (MACD) ChartAB Science S.A Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of AB Science S.A. The current adx is .

AB Science S.A Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of AB Science S.A.

AB Science S.A Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of AB Science S.A.

AB Science S.A Daily Relative Strength Index (RSI) ChartAB Science S.A Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of AB Science S.A.

AB Science S.A Daily Stochastic Oscillator ChartAB Science S.A Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of AB Science S.A.

AB Science S.A Daily Commodity Channel Index (CCI) ChartAB Science S.A Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of AB Science S.A.

AB Science S.A Daily Chande Momentum Oscillator (CMO) ChartAB Science S.A Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of AB Science S.A.

AB Science S.A Daily Williams %R ChartAB Science S.A Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of AB Science S.A.

AB Science S.A Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of AB Science S.A.

AB Science S.A Daily Average True Range (ATR) ChartAB Science S.A Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of AB Science S.A.

AB Science S.A Daily On-Balance Volume (OBV) ChartAB Science S.A Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of AB Science S.A.

AB Science S.A Daily Money Flow Index (MFI) ChartAB Science S.A Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for AB Science S.A.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-11-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-12-18MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-12-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-02MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-01-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-01-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-02-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-02-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-03-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside

6.3. Candlestick Patterns

AB Science S.A Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of AB Science S.A based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.570
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of AB Science S.A with someone you think should read this too:
  • Are you bullish or bearish on AB Science S.A? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about AB Science S.A? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about AB Science S.A

I send you an email if I find something interesting about AB Science S.A.


Comments

How you think about this?

Leave a comment

Stay informed about AB Science S.A.

Receive notifications about AB Science S.A in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.